An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why Approval Looks Likely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback